🔴 Recursion Pharmaceuticals is trading 4.2% down on October 13, 2026 amid biotech sector weakness

Recursion Pharmaceuticals is trading at $3.84, down 4.19% on October 13, 2026, with no clear company-specific catalyst identified; biotech sector weakness may be a headwind.

• The biotech sector (XBI) fell 2.01% in the regular session, while major indexes were nearly flat.
• A prior-session decline of 8.03% adds to recent volatility but does not establish a separate cause for today’s move.
• Recent biotech commentary cites cautious investor sentiment amid disappointing trial results and rising rates.